Stock listing

Santhera Pharmaceuticals Holding Ag

Selected listing: S3F0 · BX · CHF · CH

Santhera Pharmaceuticals Holding Ag (BX Swiss: S3F0), Health Technology. Latest release Jul 13, 2026: Santhera Expands Biomedica Agreement to Extend AGAMREE®…

S3F0:BXCHFCHUpdated October 2, 2026

Ticker: BX Swiss: S3F0
Asset type: Stock
Sector: Health Technology
Industry: Pharmaceuticals: Major
Exchange: BX Swiss
Currency: CHF

Latest news from Santhera Pharmaceuticals Holding Ag

Santhera Expands Biomedica Agreement to Extend AGAMREE® (Vamorolone) Distribution Across Central Asia and the Caucasus

July 13, 2026

Santhera Announces Orphan Drug and Priority Review Designations for AGAMREE® (Vamorolone) in South Korea

June 2, 2026

Santhera Proposes Dr. Srishti Gupta as New Member of the Board of Directors

April 30, 2026

Santhera Announces Positive AIFA Board Decision on Reimbursement of AGAMREE® (vamorolone) in Italy

April 28, 2026

Santhera Pharmaceuticals Full Year Results for the Year Ended 31 December 2025

April 28, 2026

All Santhera Pharmaceuticals Holding Ag news →

Events

Replays

Santhera Pharmaceuticals Holding AG (0QN1) Q2 2026 Earnings Call
Wed, Sep 30, 2026 · 08:00 AM ET
Watch
Santhera Pharmaceuticals Holding AG (0QN1) Q4 2025 Earnings Call
Tue, Apr 28, 2026 · 08:00 AM ET
Watch
Santhera Pharmaceuticals Holding AG (0QN1) Q2 2025 Earnings Call
Tue, Sep 23, 2025 · 08:00 AM ET
Watch

Research Santhera Pharmaceuticals Holding Ag

Santhera Pharmaceuticals Holding Ag company profile

View the public company page for Santhera Pharmaceuticals Holding Ag on 6ix.

Santhera Pharmaceuticals Holding Ag news

Read company news and market updates connected to Santhera Pharmaceuticals Holding Ag.

Santhera Pharmaceuticals Holding Ag investor events

Find investor webinars, events, and replay context for Santhera Pharmaceuticals Holding Ag.